##### Table of Contents



FORM 10-Q
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
 Washington, D. C. 20549
 þ
    
    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
 For the quarterly period ended June 28, 2008
 Commission
File Number: 000-53290
 CHROMADEX CORPORATION
 Delaware
(State or other jurisdiction of incorporation
or organization)
    
    26-2940963
(I.R.S. Employer Identification No.)
 
   o þ
  Large accelerated filer o
    
    Accelerated filer o
    
    Non-accelerated filer o
    
    Smaller reporting company þ
  o þ




---



##### 



CHROMADEX CORPORATION
2008 QUARTERLY REPORT ON FORM 10-Q
 TABLE OF CONTENTS
 PART I  FINANCIAL INFORMATION (UNAUDITED)ITEM 1. FINANCIAL STATEMENTS:CONSOLIDATED BALANCE SHEETS AS OF JUNE 28, 2008 AND DECEMBER 29,
2007 (UNAUDITED)
    
    
    3CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE THREE MONTHS ENDED
JUNE 28, 2008 AND JUNE 30, 2007 (UNAUDITED)
    
    
    4CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE SIX MONTHS ENDED
JUNE 28, 2008 AND JUNE 30, 2007 (UNAUDITED)
    
    
    5CONSOLIDATED STATEMENTS OF STOCK HOLDERS EQUITY AS OF JUNE 28,
2008 (UNAUDITED)
    
    
    6CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE SIX MONTHS ENDED
JUNE 28, 2008 AND JUNE 30, 2007 ( UNAUDITED)
    
    
    7NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
    
    
    8-13TRANSITION
PERIOD REPORT FOR CODY RESOURCES, INC.:CONSOLIDATED BALANCE SHEET AS OF DECEMBER 29, 2007 AND DECEMBER
31, 2006
    
    
    14CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE ONE MONTH PERIOD
ENDED DECEMBER 29, 2007 AND FOR THE PERIODS BEGINNING AT INCEPTION AND ENDING
DECEMBER 29, 2007 AND DECEMBER 31, 2006
    
    
    15CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE ONE MONTH PERIOD
ENDED DECEMBER 29, 2007 AND FOR THE PERIODS BEGINNING AT INCEPTION AND ENDING
DECEMBER 29, 2007 AND DECEMBER 31, 2006
    
    
    16NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
    
    
    17ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS
    
    
    18-22ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET
RISK
    
    
    22ITEM 4. CONTROLS AND PROCEDURES
    
    
    23PART II  OTHER INFORMATIONITEM 1. LEGAL PROCEEDINGS
    
    
    24ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND
USE OF PROCEEDS
    
    
    24ITEM 3. DEFAULTS UPON SENIOR SECURITIES
    
    
    24ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
    
    
    24ITEM 5. OTHER INFORMATION
    
    
    25ITEM 6. EXHIBITS
    
    
    26SIGNATURES
    
    
    27Exhibit 10.1Exhibit 31.1Exhibit 31.2Exhibit 32
   2




---



##### Table of Contents



PART I  FINANCIAL INFORMATION (UNAUDITED)
 
 ITEM 1. FINANCIAL STATEMENTS
 ChromaDex Corporation and Subsidaries
 
 Condensed Consolidated Balance Sheets (Unaudited)
 June 28, 2008
    
    
    December 29, 2007AssetsCurrent AssetsCash
    
    $
    2,415,620
    
    
    $
    303,785Trade receivables, net
    
    
    504,351
    
    
    
    375,233Inventories
    
    
    578,505
    
    
    
    497,635Prepaid expenses and other
    
    
    113,083
    
    
    
    60,264Total current assets
    
    
    3,611,559
    
    
    
    1,236,917Property and Equipment, net
    
    
    1,310,091
    
    
    
    1,132,823Deposits and Other Noncurrent AssetsDeposits
    
    
    49,821
    
    
    
    63,976Intangible assets, Net
    
    
    430,124
    
    
    
    487,030479,945
    
    
    
    551,006$
    5,401,595
    
    
    $
    2,920,746Liabilities and Stockholders EquityCurrent LiabilitiesAccounts payable
    
    $
    547,455
    
    
    $
    500,538Accrued expenses
    
    
    316,152
    
    
    
    351,926Notes payable
    
    
    959,617
    
    
    
    Current maturities of capital lease obligations
    
    
    79,378
    
    
    
    74,571Due to officers
    
    
    1,178,206
    
    
    
    1,167,822Customer deposits and other
    
    
    46,418
    
    
    
    117,969Total current liabilities
    
    
    3,127,226
    
    
    
    2,212,826Capital Lease Obligations, less current maturities
    
    
    111,835
    
    
    
    152,766Deferred Rent
    
    
    147,888
    
    
    
    158,839Stockholders EquityCommon stock, $.001 par value; authorized 50,000,000
shares; issued and
outstanding 2008 28,022,134 shares; 2007 22,040,797 shares
    
    
    28,022
    
    
    
    220,408Additional paid-in capital
    
    
    7,826,686
    
    
    
    5,271,389Accumulated deficit
    
    
    (5,840,062
    )
    
    
    (5,095,482
    )2,014,646
    
    
    
    396,315$
    5,401,595
    
    
    $
    2,920,746
   3




---



##### Table of Contents



ChromaDex Corporation and Subsidaries
 
 Condensed Consolidated Statements of Operations (Unaudited)
 Three Months endingJune 28, 2008
    
    
    June 30, 2007Sales
    
    $
    1,198,885
    
    
    $
    997,087Cost of goods sold
    
    
    832,905
    
    
    
    741,227Gross profit
    
    
    365,980
    
    
    
    255,860Operating expenses:Selling
    
    
    159,558
    
    
    
    74,015General and administrative
    
    
    832,374
    
    
    
    304,897991,932
    
    
    
    378,912Operating loss
    
    
    (625,952
    )
    
    
    (123,052
    )Nonoperating (income) expenses:Interest expense
    
    
    7,052
    
    
    
    7,156Interest income
    
    
    (11,550
    )
    
    
    (16,253
    )Other
    
    
    222
    
    
    
    (830
    )(4,276
    )
    
    
    (9,926
    )Income taxes
    
    
    
    
    
    
    800Net loss
    
    $
    (621,676
    )
    
    $
    (113,926
    )Basic and Diluted loss per common share
    
    $
    (0.03
    )
    
    $
    (0.01
    )Basic and Diluted average common shares outstanding
    
    
    24,755,583
    
    
    
    22,011,549
   4




---



##### Table of Contents



ChromaDex Corporation and Subsidaries
 
 Condensed Consolidated Statements of Operations (Unaudited)
 Six Months endingJune 28, 2008
    
    
    June 30, 2007Sales
    
    $
    2,258,601
    
    
    $
    2,203,980Cost of goods sold
    
    
    1,493,177
    
    
    
    1,405,513Gross profit
    
    
    765,424
    
    
    
    798,467Operating expenses:Selling
    
    
    331,542
    
    
    
    174,571General and administrative
    
    
    1,175,112
    
    
    
    624,2211,506,654
    
    
    
    798,792Operating loss
    
    
    (741,230
    )
    
    
    (325
    )Nonoperating (income) expenses:Interest expense
    
    
    14,668
    
    
    
    16,790Interest income
    
    
    (11,954
    )
    
    
    (16,875
    )Other
    
    
    638
    
    
    
    (107
    )3,352
    
    
    
    (192
    )Income taxes
    
    
    
    
    
    
    800Net loss
    
    $
    (744,582
    )
    
    $
    (933
    )Basic and Diluted loss per common share
    
    $
    (0.03
    )
    
    $
    (0.00
    )Basic and Diluted average common shares outstanding
    
    
    23,611,855
    
    
    
    22,011,549
   5




---



##### Table of Contents



ChromaDex Corporation and Subsidaries
 
 Statement of Stockholder Equity (Unaudited)
As of June 28, 2008
 Additional
    
    
    
    
    
    
    TotalCommon
    
    
    Paid-in
    
    
    Accumulated
    
    
    StockholderShares
    
    
    Stock
    
    
    Capital
    
    
    Deficit
    
    
    EquityAs of December 30,2007
    
    
    22,040,797
    
    
    $
    220,408
    
    
    $
    5,271,389
    
    
    $
    (5,095,481
    )
    
    $
    396,315Stock-based compensation
    
    
    
    
    
    
    
    
    
    
    184
    
    
    
    
    
    
    
    184Issuance of common stock
    
    
    1,612,481
    
    
    
    16,125
    
    
    
    1,946,377
    
    
    
    
    
    
    
    1,962,502Net loss
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (122,906
    )
    
    
    (122,906
    )Balance, March 29, 2008
    
    
    23,653,278
    
    
    $
    236,533
    
    
    $
    7,217,952
    
    
    $
    (5,218,387
    )
    
    $
    2,236,097Stock-based compensation
    
    
    
    
    
    
    
    
    
    
    33,590
    
    
    
    
    
    
    
    33,590Issuance of common stock
    
    
    1,091,638
    
    
    
    10,916
    
    
    
    1,315,335
    
    
    
    
    
    
    
    1,326,252Effect of reverse merger with Cody Resources Inc.
    
    
    4,500,013
    
    
    
    (207,200
    )
    
    
    207,200
    
    
    
    
    
    
    
    Repurchase and cancellation of Bayer Shares
    
    
    (1,222,795
    )
    
    
    (12,228
    )
    
    
    (947,390
    )
    
    
    
    
    
    
    (959,617
    )Net loss
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (621,676
    )
    
    
    (621,676
    )Balance, June 28, 2008
    
    
    28,022,134
    
    
    $
    28,022
    
    
    $
    7,826,688
    
    
    $
    (5,840,062
    )
    
    $
    2,014,646
   6




---



##### Table of Contents



ChromaDex Corporation and Subsidaries
 
 Condensed Consolidated Statements of Cash Flows (Unaudited)
 Six Months endingJune 28, 2008
    
    
    June 30, 2007Cash Flows from Operating ActivitiesNet loss
    
    $
    (744,582
    )
    
    $
    (933
    )Adjustments to reconcile net loss to net cash
used in operating activitiesDepreciation
    
    
    123,248
    
    
    
    118,525Amortization of intangibles
    
    
    56,906
    
    
    
    58,000Stock-based compensation expense
    
    
    33,776
    
    
    
    7(Increase) decrease inTrade receivables
    
    
    (129,118
    )
    
    
    (20,619
    )Inventories
    
    
    (80,870
    )
    
    
    (146,733
    )Prepaid and other expenses
    
    
    (52,819
    )
    
    
    18,841Deposits
    
    
    14,155
    
    
    
    (34,649
    )Increase (decrease) inAccounts payable
    
    
    46,917
    
    
    
    178,507Accrued expenses
    
    
    (35,774
    )
    
    
    (246,830
    )Customer deposits and other liabilities
    
    
    (71,551
    )
    
    
    (72,130
    )Deferred rent
    
    
    (10,951
    )
    
    
    74,625Net cash (used in) operating activities
    
    
    (850,663
    )
    
    
    (73,389
    )Cash Flows From Investing ActivitiesPurchases of property and equipment
    
    
    (300,516
    )
    
    
    (88,134
    )Net cash (used in) investing activities
    
    
    (300,516
    )
    
    
    (88,134
    )Cash Flows From Financing ActivitiesPrincipal payments on capital leases
    
    
    (36,124
    )
    
    
    (33,861
    )Principal payments on long-term debt
    
    
    
    
    
    
    (112,500
    )Proceeds from issuance of common stock
    
    
    3,288,754
    
    
    
    Due to Officers
    
    
    10,384
    
    
    
    79,398Net cash provided by financing activities
    
    
    3,263,014
    
    
    
    (66,963
    )Net increase (decrease) in cash
    
    
    2,111,835
    
    
    
    (228,486
    )Cash:Beginning
    
    
    303,785
    
    
    
    424,965Ending
    
    $
    2,415,620
    
    
    $
    196,479Supplemental Disclosures of Cash Flow InformationCash payments for interest
    
    $
    14,668
    
    
    $
    16,790Supplemental Schedules of Noncash Investing and Financing ActivitiesCapital lease obligation incurred for the purchase of equipment
    
    $
    
    
    
    $
    75,568Note payable incurred for repurchase of common stock
    
    $
    959,617
    
    
    
    
   7




---



##### Table of Contents



Note 1. Interim Financial Statements
  Accounting Treatment of the Merger; Financial Statement Presentation
  Note 2. Nature of Business and Significant Accounting Policies
 Nature of business
 Basis of presentation
  8




---



##### Table of Contents



Change in fiscal year ending
 Earnings per share
 Three Months ending
    
    
    Six Months endingJune 28, 2008
    
    
    June 30, 2007
    
    
    June 28, 2008
    
    
    June 30, 2007Basic average common shares outstanding
    
    
    24,755,583
    
    
    
    22,011,549
    
    
    
    23,611,855
    
    
    
    22,011,549Dilutive potential sharesWarrants and options in the money, net
    
    
    2,682,771
    
    
    
    
    
    
    
    2,682,771
    
    
    
    Weighted average common shares
outstanding assuming dilution
    
    
    27,438,354
    
    
    
    22,011,549
    
    
    
    26,294,626
    
    
    
    22,011,549
 Note 3. Financial Instruments
 Fair Value Measurements
      9




---



##### Table of Contents



Financial Assets
    
    Total
    
    
    Level 1
    
    
    Level 2
    
    
    Level 3Cash
    
    $
    2,416,000
    
    
    $
    2,416,000
    
    
    $
    
    
    
    $
    Total financial assets as fair value
    
    $
    2,416,000
    
    
    $
    2,416,000
    
    
    $
    
    
    
    $
    
 Financial Liabilities
    
    Total
    
    
    Level 1
    
    
    Level 2
    
    
    Level 3Notes Payable(a)
    
    $
    960,000
    
    
    $
    
    
    
    $
    960,000
    
    
    $
    Capital Lease Obligations(b)
    
    
    191,000
    
    
    
    
    
    
    
    191,000
    
    
    
    Total financial liabilities as fair value
    
    $
    1,151,000
    
    
    $
    
    
    
    $
    960,000
    
    
    $
    
 (a)
    
    Based on the bank prime rate plus a margin of 2%(b)
    
    Incremental interest rates range from 9.7% to 22.5% Note 4. Notes Payable
  Note 5. Capital Stock
  Summary of Significant Assumptions
    
    June 28, 2008Expected Term
    
    
    5.00Expected Volatility
    
    
    22.20
    %Expected Dividends
    
    
    0.00
    %Risk Free Rate of Return
    
    
    2.65
    %
   10




---



##### Table of Contents



Note 6. Stock Options and Unearned Stock-Based Compensation
   For the three months ended
    
    
    For the six months endedJune 28, 2008
    
    
    June 30, 2007
    
    
    June 28, 2008
    
    
    June 30, 2007Total share-based compensation expense
    
    $
    33,590
    
    
    $
    
    
    
    $
    33,776
    
    
    $
    Weighted average grant date fair value, options
    
    $
    0.40
    
    
    $
    
    
    
    $
    0.40
    
    
    
    0Total unrecognized compensation cost
    
    $
    687,169
    
    
    $
    
    
    
    $
    687,169
    
    
    $
    Remaining weighted average period cost will be
recognized over
    
    
    3.75
    
    
    
    0
    
    
    
    3.75
    
    
    
    0
 Note 7. Related Party Transactions
  Note 8. Managements Plans for Continuing Operations and Subsequent Events
   11




---



##### Table of Contents



12




---



##### Table of Contents



TRANSITION
PERIOD REPORT FOR CODY RESOURCES, INC. (UNAUDITED)
  13




---



##### Table of Contents



CODY RESOURCES, INC.
 
  29-Dec
    
    
    31-Dec2007
    
    
    2006ASSETSCURRENT ASSETSCash
    
    $
    580
    
    
    $
    26,213Total Current Assets
    
    
    580
    
    
    
    26,213TOTAL ASSETS
    
    $
    580
    
    
    $
    26,213LIABILITIES AND STOCKHOLDERS EQUITYCURRENT LIABILITIESAccounts payable
    
    $
    501
    
    
    $
    501Total Current Liabilities
    
    
    501
    
    
    
    501STOCKHOLDERS EQUITYCommon stock; $0.001 par value, 50,000,000
shares authorized, 1,390,0
    
    
    1,390
    
    
    
    1,390Additional paid-in capital
    
    
    38,610
    
    
    
    38,610Stock subscription receivable
    
    
    
    
    
    
    -875Accumulated deficit
    
    
    -39,921
    
    
    
    -13,413Total Stockholders Equity (Deficit)
    
    
    79
    
    
    
    25,712TOTAL LIABILITIES AND STOCKHOLDERS EQUITY
    
    $
    580
    
    
    $
    26,213
   14




---



##### Table of Contents



CODY RESOURCES, INC.
 
  Since Inception
    
    
    Since InceptionFor the
    
    
    on July 20,
    
    
    on July 20,Period December 1
    
    
    2006 Through
    
    
    2006 Throughto December 29,
    
    
    December 31,
    
    
    December 29,2007
    
    
    2006
    
    
    2007REVENUES
    
    $
    
    
    
    $
    
    
    
    $
    COST OF GOODS SOLD
    
    
    
    
    
    
    
    
    
    
    GROSS PROFIT
    
    
    
    
    
    
    
    
    
    
    OPERATING EXPENSESGeneral and administrative expenses
    
    
    -25
    
    
    
    1,077
    
    
    
    19,195Professional fees
    
    
    12,000
    
    
    
    12336
    
    
    
    20,625Total Operating Expenses
    
    
    11,975
    
    
    
    13,413
    
    
    
    39,820NET LOSS
    
    $
    -11,975
    
    
    $
    -13,413
    
    
    $
    -39,820BASIC AND DILUTED LOSS PER SHARE
    
    $
    (0.01
    )
    
    $
    (0.01
    )WEIGHTED AVERAGE NUMBER OF SHARES
OUTSTANDING
    
    
    1,390,000
    
    
    
    1,390,000
   15




---



##### Table of Contents



CODY RESOURCES, INC.
 
  Since Inception
    
    
    Since InceptionFor the
    
    
    on July 20,
    
    
    on July 20,Period December 1
    
    
    2006 Through
    
    
    2006 Throughto December 29,
    
    
    December 31,
    
    
    December 29,2007
    
    
    2006
    
    
    2007CASH FLOWS FROM OPERATING ACTIVITIESNet income (loss)
    
    $
    -11,975
    
    
    $
    -13,413
    
    
    $
    -39,921Adjustments to reconcile net loss to net cash
used by operating activities:Common stock issued for debt
    
    
    
    
    
    
    1,000
    
    
    
    1,000Changes in operating assets and liabilitiesIncrease (decrease) in accounts payable
    
    
    
    
    
    
    501
    
    
    
    501Net Cash Used by Operating Activities
    
    
    -11,975
    
    
    
    -11,912
    
    
    
    -38,420CASH FLOWS FROM INVESTING ACTIVITIES
    
    
    
    
    
    
    
    
    
    
    CASH FLOWS FROM FINANCING ACTIVITIESCommon stock issued for cash
    
    
    
    
    
    
    38,125
    
    
    
    39,000Net Cash Used by Financing Activities
    
    
    
    
    
    
    38,125
    
    
    
    39,000NET INCREASE IN CASH
    
    
    -11,975
    
    
    
    26,213
    
    
    
    580CASH AT BEGINNING OF PERIOD
    
    
    12,555
    
    
    
    
    
    
    
    CASH AT END OF PERIOD
    
    $
    580
    
    
    $
    26,213
    
    
    $
    580SUPPLIMENTAL DISCLOSURES OF CASH
FLOW INFORMATIONCASH PAID FOR:Interest
    
    $
    
    
    
    $
    
    
    
    $
    Income Taxes
    
    $
    
    
    
    $
    
    
    
    $
    
   16




---



##### Table of Contents



NOTES TO TRANSITION PERIOD FINANCIAL STATEMENTS FOR CODY RESOURCES, INC.
 NOTE 1  CONDENSED FINANCIAL STATEMENTS
   NOTE 2  GOING CONCERN
      17




---



##### Table of Contents



ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS
 GENERAL
 This Quarterly Report on Form 10-Q (theForm 10-Q) contains forward-looking statements, as
defined in Section 21E of the Securities Exchange Act of 1934, as amended. These statements reflect
the Companys current expectations of the future results of its operations, performance and
achievements. Forward-looking statements are covered under the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. The Company has tried, wherever possible, to
identify these statements by using words such as anticipates, believes, estimates, expects,
plans, intends and similar expressions. These statements reflect managements current beliefs
and are based on information now available to it. Accordingly, these statements are subject to
certain risks, uncertainties and contingencies that could cause the Companys actual results,
performance or achievements in 2008 and beyond to differ materially from those expressed in, or
implied by, such statements. These risks, uncertainties, factors and other risks are set forth
under the caption Risk Factors in the Companys Current Report on Form 8-K filed June 24, 2008.
Readers of this Quarterly Report on Form 10-Q should not place undue reliance on any
forward-looking statements. Except as required by federal securities laws, the Company undertakes
no obligation to update or revise these forward-looking statements to reflect new events or
uncertainties.
 Overview
   Results of Operations
   18




---



##### Table of Contents



19




---



##### Table of Contents



Net Sales
 Net sales consist of Reference Standards and Contract Service sales less returns, discounts
and freight costs.
 Cost of Goods Sold
 Costs of goods sold include Raw Materials, Labor, and Overhead.
 Gross Profit
 Gross profit is net sales less the cost of sales and is affected by a number of factors
including product mix, competitive pricing and costs of products and services.
  20




---



##### Table of Contents



Operating Expenses-Sales and Marketing
 Sales and Marketing Expenses consist of salaries, commissions to employees and advertising and
marketing
 Operating Expenses-General and Administrative
 General and Administrative Expenses consist of research and development, general company
administration, IT, accounting and executive management.
 Non-operating Expenses- Interest Expense
 Interest expense consists of interest on capital leases
 Non-operating Expenses- Interest Income
 Interest Income consists of interest earned on short term investment and notes receivable
 Depreciation and Amortization
   21




---



##### Table of Contents



Liquidity and Capital Resources
   Dividend policy
  Off-Balance Sheet Arrangements
  Contractual Obligations
  
 ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
   22




---



##### Table of Contents



ITEM 4. CONTROLS AND PROCEDURES
 Evaluation of Disclosure Controls and Procedures
  Changes in Internal Controls
   23




---



##### Table of Contents



PART II  OTHER INFORMATION
 
 ITEM 1. LEGAL PROCEEDINGS
  
 ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
  ISSUER PURCHASES OF EQUITY SECURITIES
 (d) Maximumnumber (orapproximate dollar(c) Total Number of
    
    
    value) of shares (orShares (or Units)
    
    
    units) that may yet(a) Total Number of
    
    
    (b) Average Price
    
    
    purchased as part of
    
    
    be purchased underShares (or Units)
    
    
    paid per Share (or
    
    
    publicly announced
    
    
    the Plans orPeriod
    
    Purchased
    
    
    Unit)
    
    
    programs
    
    
    ProgramsMonth #1
May 31 to
June 28, 2008
    
    
    1,222,795
    
    
    $
    0.82
    
    
    
    
    
    
    
    Total
    
    
    1,222,795
    
    
    $
    0.82
    
    
    
    
    
    
    
    
 (1)
    
    On June 18, 2008, the Company repurchased 1,222,795 shares of its outstanding common stock
from Bayer Innovation GmbH (formerly Bayer Innovation Beteiligungsgescellschatt mbH), for an
aggregate purchase price of $1,002,691.90 pursuant to a Share Redemption Agreement. 
 ITEM 3. DEFAULTS UPON SENIOR SECURITIES
  
 ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
 Cody Resources, Inc. (NV)
    24




---



##### Table of Contents



ChromaDex Corporation (DE)
   ChromaDex, Inc. (CA)
   
 ITEM 5. OTHER INFORMATION
   25




---



##### Table of Contents



ITEM 6. EXHIBITS
 Exhibit No.
    
    Description of Exhibits2.1
    
    
    Agreement and Plan of Merger, dated as of May 21, 2008, among Cody,
CDI Acquisition, Inc. and ChromaDex, Inc. (incorporated by reference
from, and filed as Exhibit 2.1 to the Companys Current Report on
Form 8-K filed June 24, 2008)3.1
    
    
    Amended and Restated Certificate of Incorporation of ChromaDex
Corporation, a Delaware corporation (incorporated by reference from,
and filed as Exhibit 3.1 to the Companys Current Report on Form 8-K
filed June 24, 2008)3.2
    
    
    Bylaws of ChromaDex Corporation, a Delaware corporation (incorporated
by reference from, and filed as Exhibit 3.2 to the Companys Current
Report on Form 8-K filed June 24, 2008)10.1
    
    
    Technology License Agreement dated June 30, 2008 between The Research
Foundation of the State University of New York and ChomaDex, Inc.*10.2
    
    
    Standard Industrial/Commercial Multi-Tenant Lease-Net dated December
19, 2006 and First Amendment thereto, dated as of June 26, 2008, by
and between ChromaDex, Inc. and SCIF Portfolio II, LLC (incorporated
by reference from, and filed as Exhibits 10.7 and 10.1 on the
Companys Current Report on Forms 8-K filed June 24, 2008 and July
23, 2008)10.3
    
    
    Stock Redemption Agreement, dated June 18, 2008 between ChromaDex,
Inc. and Bayer Innovation GmbH (formerly named Bayer Innovation
Beteiligungsgesellschaft mbH) (incorporated by reference from, and
filed as Exhibit 10.13 to the Companys Current Report on Form 8-K
filed June 24, 2008)10.4
    
    
    Promissory Note, dated June 18, 2008 between ChromaDex, Inc. as
borrower and Bayer Innovation GmbH as lender (incorporated by
reference from, and filed as Exhibit 10.14 to the Companys Current
Report on Form 8-K filed June 24, 2008)31.1
    
    
    Certification of the Chief Executive Officer pursuant to §240.13a-14
or §240.15d-14 of the Securities Exchange Act of 1934, as amended.31.2
    
    
    Certification of the Chief Financial Officer pursuant to §240.13a-14
or §240.15d-14 of the Securities Exchange Act of 1934, as amended.32
    
    
    Certification pursuant to 18 U.S.C. Section 1350 (as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002).
 *
    
    This Exhibit has been filed separately with the Commission pursuant to an application for
confidential treatment. The confidential portions of this Exhibit have been omitted and are
marked by an asterisk.  26




---



##### Table of Contents



SIGNATURES
  ChromaDex Corporation(Registrant)Date: August 12, 2008/s/ THOMAS C. VARVAROThomas C. VarvaroChief Financial Officer  27




---



##### Table of Contents



EXHIBIT INDEX
 Exhibit No.
    
    Description of Exhibits10.1
    
    
    Technology License Agreement dated June 30, 2008 between The Research
Foundation of the State University of New York and ChomaDex, Inc.*31.1
    
    
    Certification of the Chief Executive Officer pursuant to §240.13a-14
or §240.15d-14 of the Securities Exchange Act of 1934, as amended.31.2
    
    
    Certification of the Chief Financial Officer pursuant to §240.13a-14
or §240.15d-14 of the Securities Exchange Act of 1934, as amended.32
    
    
    Certification pursuant to 18 U.S.C. Section 1350 (as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002).
 *
    
    This Exhibit has been filed separately with the Commission pursuant to an application for
confidential treatment. The confidential portions of this Exhibit have been omitted and are marked
by an asterisk.  28